The aggressive type of cancer accounts for 13% of all lung cancer cases worldwide
Category: News
The report includes five recommendations for the government to address these issues
The projects will focus on healthcare in LMICs in the event of extreme weather
The phase 1/2 Mobilize trial is evaluating the safety and efficacy of mRNA-4359
The platform delivers digitalised patient data to improve clinical trials and development
The chip removes cells, which could become tumours, before they are implanted in a patient
OART is increasingly emerging to assess and adapt treatment for cancer patients
The rare neurodevelopmental condition CDKL5 is characterised by early-onset epilepsy
The cell could be a target for new immunotherapies for the chronic disease
The committee has advised that the vaccine should be given to those at the highest risk